Research exploring the use of Chaga mushroom and birch tree sap extracts to mask or minimize the salty taste of electrolyte solutions while delivering added health benefits. These natural ingredients contain antioxidants and anti-inflammatory compounds that may improve consumer acceptability of electrolyte products and support wellness.
This research investigates the use of natural extracts from Chaga mushroom and birch tree sap to reduce the perceived salty taste of electrolyte solutions. Both ingredients are rich in antioxidants, including vitamin C, and exhibit anti-inflammatory properties. The goal is to develop formulations that improve the sensory experience of electrolyte products while delivering additional health benefits to consumers. Potential long-term applications include supporting metabolic health, with future studies planned to evaluate effects in diabetes.
Key features:
The research is at an early stage, with initial validation confirming the presence of antioxidants and anti-inflammatory compounds in both Chaga and birch tree sap extracts. Future validation includes standardizing antioxidant activity, conducting toxicity studies in animal models, developing formulations for sensory and consumer acceptability testing, and ultimately running a randomized placebo-controlled crossover study in diabetes. Activities 1 through 3 are planned within two years, with activity 4 in year three. Additional partnerships and resources are sought to advance this work.
The University of Manitoba is a comprehensive public research university in Winnipeg with a broad portfolio spanning discovery to translation. Industry engages through an on-campus research and technology park that colocates companies with university labs, and through a health sciences campus embedded in the city’s hospital district for clinical studies and clinical-grade prototyping. A well-established co-op and internship ecosystem and the region’s logistics hub position make collaboration, field trials, and pilot-scale testing accessible. Research is supported by competitive funding from NSERC, CIHR, SSHRC, and the Canada Foundation for Innovation. A dedicated technology transfer office provides IP strategy, licensing, and startup support with flexible agreements for corporate partners.